BELRAPZO

Serial Number 87866979
Registration 5869212
702

Registration Progress

Application Filed
Apr 6, 2018
Under Examination
Oct 30, 2018
Approved for Publication
Sep 4, 2018
Published for Opposition
Sep 4, 2018
Registered
Sep 24, 2019

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20190924) (Grace Period Filing)
Due: Mar 24, 2026 Grace Period - 80 days
Original deadline was Sep 24, 2025 (overdue)

Trademark Image

BELRAPZO

Basic Information

Serial Number
87866979
Registration Number
5869212
Filing Date
April 6, 2018
Registration Date
September 24, 2019
Published for Opposition
September 4, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
702
Status Date
Feb 6, 2025
Registration
Registered
Classes
005

Rights Holder

Eagle Pharmaceuticals, Inc.

03
Address
50 Tice Boulevard, Suite 315
Woodcliff Lake, NJ 07677

Ownership History

Eagle Pharmaceuticals, Inc.

Original Applicant
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals, Inc.

Owner at Publication
03
Woodcliff Lake, NJ

Eagle Pharmaceuticals, Inc.

Original Registrant
03
Woodcliff Lake, NJ

Legal Representation

Attorney
Perry J. Viscounty

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20190924)
Due Date
September 24, 2025
Grace Period Ends
March 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

24 events
Date Code Type Description Documents
Feb 6, 2025 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Feb 6, 2025 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Feb 6, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 24, 2024 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Sep 24, 2024 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Sep 24, 2019 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 23, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 22, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Aug 21, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 25, 2019 IUAF S USE AMENDMENT FILED Loading...
Aug 21, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 25, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Mar 6, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 4, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 4, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 30, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 4, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 4, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 15, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 25, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 24, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 16, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 10, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer
First Use Anywhere: May 23, 2019
First Use in Commerce: Jun 3, 2019

Classification

International Classes
005